Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder.
Martinez JM, Ferguson MB, Pangallo BA, Oakes TM, Sparks J, Dellva MA, Zhang Q, Liu P, Bangs M, Ahl J, Goldberger C. Martinez JM, et al. Among authors: bangs m. Drugs Context. 2015 May 13;4:212279. doi: 10.7573/dic.212279. eCollection 2015. Drugs Context. 2015. PMID: 26005493 Free PMC article.
Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
Ball SG, Ferguson MB, Martinez JM, Pangallo BA, Nery ES, Dellva MA, Sparks J, Zhang Q, Liu P, Bangs M, Goldberger C. Ball SG, et al. Among authors: bangs m. J Clin Psychiatry. 2016 May;77(5):635-42. doi: 10.4088/JCP.14m09619. J Clin Psychiatry. 2016. PMID: 27035159 Clinical Trial.
The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports.
Perahia DG, Bangs ME, Zhang Q, Cheng Y, Ahl J, Frakes EP, Adams MJ, Martinez JM. Perahia DG, et al. Among authors: bangs me. Drug Healthc Patient Saf. 2013 Nov 25;5:211-9. doi: 10.2147/DHPS.S45445. eCollection 2013. Drug Healthc Patient Saf. 2013. PMID: 24348072 Free PMC article.
Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.
Ball SG, Atkinson S, Sparks J, Bangs M, Goldberger C, Dubé S. Ball SG, et al. Among authors: bangs m. J Clin Psychopharmacol. 2015 Jun;35(3):266-72. doi: 10.1097/JCP.0000000000000302. J Clin Psychopharmacol. 2015. PMID: 25815754 Clinical Trial.
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
Atomoxetine ADHD and Comorbid MDD Study Group; Bangs ME, Emslie GJ, Spencer TJ, Ramsey JL, Carlson C, Bartky EJ, Busner J, Duesenberg DA, Harshawat P, Kaplan SL, Quintana H, Allen AJ, Sumner CR. Atomoxetine ADHD and Comorbid MDD Study Group, et al. J Child Adolesc Psychopharmacol. 2007 Aug;17(4):407-20. doi: 10.1089/cap.2007.0066. J Child Adolesc Psychopharmacol. 2007. PMID: 17822337 Clinical Trial.
283 results